Back to Careers

EARD 2022: Mapping Secreted Proteins to Unmet Medical Needs by Dr. Thach Mai at Juvena August 2022

Back to Careers

CSO and Co-Founder Dr. Jeremy O’Connell presents at FASEB Industry Panel Jul. 2022

Back to Careers

CEO Hanadie Yousef was honored to represent Juvena Therapeutics at BIO International Convention in June 2022, where she gave a Company Presentation at the emerging company showcase. She had numerous meetings with exciting companies and investors focused on partnerships and was all around inspired by the exceptional attendees, sponsors, and organizers. Thanks to The National Institutes of Health for sponsoring the Innovation Zone and Juvena’s attendance

Back to Careers

Juvena Therapeutics Awarded Highly Competitive 3.9M CIRM TRAN1 Grant to Advance Lead Program, JUV-161, to Treat Myotonic Dystrophy Type 1

Back to Careers

Hanadie served on a CEO panel with a group of portfolio companies for Bascom Ventures (part of Alumni Ventures)

Back to Careers

CIRM Awards Juvena a $3.9M TRAN1 Grant to Advance JUV-161 for Myotonic Dystrophy Type 1 (DM1)

Back to Careers

CEO Dr. Yousef Represents Juvena at Longevity Summit 2021

Back to Careers

CEO Dr. Hanadie Yousef Interviewed for Translating Aging Podcast, “The Cures Within Us”

Back to Careers

CEO Dr. Hanadie Yousef is interviewed by Ira Pastor for his Progress, Potential, and Possibilities show on Juvena’s development of Secretome Derived Therapies

juvena-logo-wht

Navigation

Contact

640 Galveston Drive
Redwood City, CA 94063
Get Directions »
650.223.5879
info@juvenatherapeutics.com

Stay in touch

Subscribe to our newsletter

By entering your email you agree to our Privacy Policy

© 2023 Juvena Therapeutics Inc. All Rights Reserved | Privacy Policy